Accelerating Global Deletion of the Abnormal Toxicity Test

Virtual event October 14th, 2021 – 12:30 -16:30 CEST
An EFPIA / AFSA collaboration event, in collaboration with IABS

Building from the results of HSI Symposium ( (Rome, 2019) and on the IABS congress ( (Bangkok, 2019), bring together a wider but specific range of key international and local stakeholders— including new ones with a keen interest in vaccine innovation and increased accessibility through diminished reliance on in vivo testing—to strategically agree on the way forward to the elimination of the ATT from the regulatory requirements for vaccines and biologicals.